Inactief instrument

Koers Albany Molecular Research, Inc. Deutsche Boerse AG

Aandelen

Duur

Periode

Stijl

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17-01-18
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	04-01-18
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19-12-17
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30-11-17
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09-11-17

Managers	Titel	Leeftijd	Van
Philip W Macnabb CEO	Chief Executive Officer	-	01-05-23
Meera Khullar CMP	Compliance Officer	-	01-03-19
Prakash Pandian CTO	Chief Tech/Sci/R&D Officer	-	01-06-18

Besturend	Titel	Leeftijd	Van
Dean Mihas BRD	Director/Board Member	57	-
Sean Cunningham BRD	Director/Board Member	48	-
William McMullan BRD	Director/Board Member	46	-

Sector

	Vaira. 1 jan.	Kapi.
MODERNA, INC.	+40,80%	53,67 mld.
LONZA GROUP AG	+35,79%	38,86 mld.
IQVIA HOLDINGS INC.	-8,05%	38,76 mld.
CELLTRION, INC.	-8,98%	27,27 mld.
ICON PUBLIC LIMITED COMPANY	+10,69%	25,91 mld.
ALNYLAM PHARMACEUTICALS, INC.	-16,21%	20,29 mld.
UNITED THERAPEUTICS CORPORATION	+31,00%	12,78 mld.
MEDPACE HOLDINGS, INC.	+28,51%	12,18 mld.
BIO-TECHNE CORPORATION	-1,67%	11,96 mld.